Theoretical Investigation of Aspirin Dosage Regimen to Exhibit Optimal Antiplatelet Effects and Decrease Risk of Upper Gastrointestinal Lesions-Reference-Cited by-同舟云学术

Theoretical Investigation of Aspirin Dosage Regimen to Exhibit Optimal Antiplatelet Effects and Decrease Risk of Upper Gastrointestinal Lesions

Published:2012 Issue:12 Volume:35 Page:2112-2118
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Yokoyama Haruko¹,Yaguchi Takehiro¹,Suzuki Yuji²,Tokuoka Kentaro³,Watanabe Masayuki²,Kitagawa Yasuhisa³,Yamada Yasuhiko¹

Affiliation:

1. Department of Clinical Evaluation of Drug Efficacy, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences

2. Departments of Pharmacy, Tokai University of Hachioji Hospital

3. Departments of Neurology, Tokai University of Hachioji Hospital

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/35/12/35_b12-00030/_pdf

Reference7 articles.

1. 3) Yajima K, Hodozuka M, Takahashi K, Tomigahara Y, Akashi T, Kawai T, Yamashina A, Kizu J. Research on incidence of upper gastrointestinal complications in patients taking low-dose aspirin and their awareness of them. J. Pharm. Health Care Sci., 35, 649–654 (2009).

2. 7) Feldman M, Shewmake K, Cryer B. Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G1113–G1120 (2000).

3. 9) Interview form of Bufferin 81 mg tablets, 2008.

4. 10) Yamamoto K, Abe M, Katashima M, Yamada Y, Sawada Y, Iga T. Pharmacodynamic analysis of antiplatelet effect of aspirin in the literature—modeling based on inhibition of cyclooxygenase in the platelet and the vessel wall endothelium—. J. Hosp. Pharm., 22, 133–141 (1996).

5. 11) Reilly IA, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood, 69, 180–186 (1987).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use;Journal of Thrombosis and Thrombolysis;2018-11-07

2. Antiplatelet effect of aspirin during 24 h in patients with type 2 diabetes without cardiovascular disease;Thrombosis Research;2018-01

3. Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium;Journal of Thrombosis and Thrombolysis;2017-12-02

4. Clinical Pharmacology and Cardiovascular Safety of Naproxen;American Journal of Cardiovascular Drugs;2016-11-08

5. Evaluation of Drug Information Service Available for Physicians regarding Low-dose Aspirin-induced Gastrointestinal Lesions;YAKUGAKU ZASSHI;2014-04-01